hyperostosis
MONDO:0002185
Excessive thickening of bone.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Hyperostosis
Hyperostosis is an excessive growth of bone. It may lead to exostosis. It occurs in many musculoskeletal disorders and from use of drugs like Isotretinoin. Disorders featuring hyperostosis include: Camurati-Engelmann disease, type 2 Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 Melorheostosis Tumoral calcinosis, hyperphosphatemic, familial, 1 Worth disease
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.